Avanos Medical Inc (AVNS)Healthcare | Medical Devices | Alpharetta, United States |
USD
|
Hot Take ↕ | Aug. 22, 2026, 8:44 a.m. UTC
The immediate catalyst here is the definitive acquisition agreement with American Industrial Partners at approximately $25 per share, which has pushed the stock to its 52-week high. This creates a strong near-term ceiling and provides a clear exit strategy for investors, justifying a neutral-to-slightly-bearish short-term stance rather than a full buy, as the upside is capped by the deal price while volatility remains elevated given the beta. However, the long-term investment case is fundamentally compromised by deteriorating financial health; the company is reporting negative earnings growth, negative quarterly earnings growth, and negative return on equity, indicating a business that is currently destroying shareholder value despite modest revenue expansion. The balance sheet is also strained with debt significantly exceeding cash reserves. Consequently, holding this stock for long-term appreciation is risky as the core business metrics are failing, making the acquisition offer the primary reason to own or hold, rather than organic growth potential. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.007953 |
| AutoETS | 0.007957 |
| MSTL | 0.018073 |
| AutoARIMA | 0.099742 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 1.53 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.015 |
| Excess Kurtosis | 0.15 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 17.696 |
| Revenue per Share | 15.429 |
| Market Cap | 1,170,726,912 |
| Forward P/E | 19.99 |
| Beta | 1.57 |
| Profit Margins | -10.39% |
| Website | https://avanos.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 1.4191675 |
| Address1 | 5,405 Windward Parkway |
| Address2 | Suite 100 South |
| All Time High | 72.96 |
| All Time Low | 9.303 |
| Ask | 0.0 |
| Ask Size | 3,560,000 |
| Audit Risk | 8 |
| Average Daily Volume10 Day | 673,208 |
| Average Volume | 1,052,956 |
| Average Volume10Days | 673,208 |
| Beta | 1.569 |
| Bid | 0.0 |
| Bid Size | 1,550,000 |
| Board Risk | 1 |
| Book Value | 16.757 |
| City | Alpharetta |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 7 |
| Country | United States |
| Currency | USD |
| Current Price | 24.99 |
| Current Ratio | 2.477 |
| Date Short Interest | 1,784,073,600 |
| Day High | 25.0 |
| Day Low | 24.98 |
| Debt To Equity | 17.696 |
| Earnings Growth | -0.217 |
| Earnings Quarterly Growth | -0.227 |
| Ebitda | 55,900,000 |
| Ebitda Margins | 0.07808 |
| Enterprise To Ebitda | 22.235 |
| Enterprise To Revenue | 1.736 |
| Enterprise Value | 1,242,951,552 |
| Exchange | NYQ |
| Exchange Timezone Name | UTC |
| Fifty Day Average | 24.9036 |
| Fifty Two Week High | 25.49 |
| Fifty Two Week Low | 9.55 |
| Financial Currency | USD |
| First Trade Date Epoch Utc | 1,784,295,000 |
| Float Shares | 46,026,430 |
| Forward Eps | 1.25 |
| Forward P E | 19.992 |
| Free Cashflow | 17,050,000 |
| Full Time Employees | 2,287 |
| Fullday Price | 24.99 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.50049 |
| Gross Profits | 358,300,000 |
| Held Percent Insiders | 0.03282 |
| Held Percent Institutions | 0.93149 |
| Implied Shares Outstanding | 46,847,816 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia. |
| Long Name | Avanos Medical Inc |
| Market Cap | 1,170,726,912 |
| Max Age | 86,400 |
| Message Board Id | finmb_251719973 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -74,400,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Open | 24.98 |
| Operating Cashflow | 36,700,000 |
| Operating Margins | 0.053790003 |
| Overall Risk | 5 |
| Payout Ratio | 0.0 |
| Phone | 844 428 2667 |
| Previous Close | 24.98 |
| Price Hint | 2 |
| Price To Book | 1.491317 |
| Price To Sales Trailing12 Months | 1.6353217 |
| Profit Margins | -0.10393 |
| Quick Ratio | 1.285 |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Regular Market Day High | 25.0 |
| Regular Market Day Low | 24.98 |
| Regular Market Open | 24.98 |
| Regular Market Previous Close | 24.98 |
| Regular Market Volume | 432,161 |
| Return On Assets | 0.0095 |
| Return On Equity | -0.09177 |
| Revenue Growth | 0.088 |
| Revenue Per Share | 15.429 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 46,847,816 |
| Shares Percent Shares Out | 0.0374 |
| Shares Short | 1,751,047 |
| Shares Short Previous Month Date | 1,781,481,600 |
| Shares Short Prior Month | 1,713,057 |
| Short Name | Avanos Medical, Inc. |
| Short Percent Of Float | 0.044 |
| Short Ratio | 2.05 |
| State | GA |
| Symbol | AVNS |
| Time Zone Full Name | America/New_York |
| Time Zone Short Name | EDT |
| Total Cash | 65,600,000 |
| Total Cash Per Share | 1.401 |
| Total Debt | 138,400,000 |
| Total Revenue | 715,900,032 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.6 |
| Trailing Peg Ratio | None |
| Two Hundred Day Average | 17.1641 |
| Underlying Symbol | AVNS |
| Uuid | 072d122b-2f4d-30a8-8d4c-00fcd10638d6 |
| Volume | 432,161 |
| Website | https://avanos.com |
| Zip | 30,004 |